References
Diamond S: Amitriptyline in the treatment of gastrointestinal disorders. Psychosomatics 5:221–224, 1964
Drossman DA, Thompson WG, Talley NJ, Funch-jensen P, Janssens J, Whitehead WE: Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Internat 3:159–172, 1990
Hislop IG: Psychological significance of the irritable colon syndrome. Gut 12:452–457, 1971
Clouse RE, Alpers DH: The relationship of psychiatric disorder to gastrointestinal illness. Annu Rev Med 37:283–295, 1986
Walker EA, Roy-Byrne PP, Katon WJ: Irritable bowel syndrome and psychiatric illness. Am J Psychiatry 147:565–572, 1990
Fava GA, Pavan L: Large bowel disorders. II. Psychopathology and alexithymia. Psychother Psychosom 27:100–105, 1976/1977
Latimer P, Sarna S, Campbell D, Latimer M, Waterfall W, Daniel EE: Colonic motor and myoelectric activity: a comparative study of normal subjects, psychoneurotic patients and patients with irritable bowel syndrome. Gastroenterology 80:893–901, 1981
Wender PH, Kalm M: Prevalence of attention deficit disorder, residual type, and other psychiatric disorders in patients with irritable colon syndrome. Am J Psychiatry 140:1579–1582, 1983
Robins LN, Helzer JE, Croughan J, Ratcliff KS: National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry 38:381–389, 1981
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. Washington, DC, American Psychiatric Association, 1987
Liss JL, Alpers D, Woodruff RA Jr: The irritable colon syndrome and psychiatric illness. Dis Nerv Syst 34:151–157, 1973
Young SJ, Alpers DH, Norland CC, Woodruff RA Jr: Psychiatric illness and the irritable bowel syndrome: Practical implications for the primary physician. Gastroenterology 70:162–166, 1976
Ford MJ, Miller P McC, Eastwood J, Eastwood MA: Life events, psychiatric illness and the irritable bowel syndrome. Gut 28:160–165, 1987
Walker EA, Roy-Byrne PP, Katon WJ, Li L, Amos D, Jiranek G: Psychiatric illness and irritable bowel syndrome: A comparison with inflammatory bowel disease. Am J Psychiatry 147:1656–1661, 1990
Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD Jr., Regier DA: Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 41:949–958, 1984
Cormier LE, Katon W, Russo J, Hollifield M, Hall ML, Vitaliano PP: Chest pain with negative cardiac diagnostic studies: Relationship to psychiatric illness. J Nerv Mental Dis 176:351–358, 1988
Beitman BD, Basha I, Flaker G, DeRosear L, Mukerji V, Lamberti JW: Major depression in cardiology chest pain patients without coronary artery disease and with panic disorder. J Affective Disord 13:51–59, 1987
Wulsin LR, Hillard JR, Geier P, Hissa D, Rouan GW: Screening emergency room patients with atypical chest pain for depression and panic disorder. Int J Psychiatry Med 18:315–323, 1988
Bass C, Wade C: Chest pain with normal coronary arteries: a comparative study of psychiatric and social morbidity. Psychol Med 14:51–61, 1984
Clouse RE, Lustman PJ: Psychiatric illness and contraction abnormalities of the esophagus. N Engl J Med 309:1337–1342, 1983
Richter JE, Baldi F, Clouse RE, Diamant NE, Janssens J, Staiano A: Functional oesophageal disorders. Gastroenterol Int 5:3–17, 1992
Richter JE, Obrecht WF, Bradley LA, Young LD, Anderson KO: Psychological comparison of patients with nutcracker esophagus and irritable bowel syndrome. Dig Dis Sci 31:131–138, 1986
Clouse RE, Lustman PJ: Value of recent psychological symptoms in identifying patients with esophageal contraction abnormalities. Psychosom Med 51:570–576, 1989
Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS: Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities: A double-blind, placebo-controlled trial. Gastroenterology 92:1027–1036, 1987
Magni G, di Mario F, Bernasconi G, Mastropaolo G: DSM-III diagnoses associated with dyspepsia of unknown cause. Am J Psychiatry 144:1222–1223, 1987
Clouse RE: Psychiatric disorders in patients with esophageal disease. Med Clin North Am 75:1081–1096, 1991
Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, Burger AL: Psychosocial factors in the irritable bowel syndrome: A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 95:701–708, 1987
Smith RC, Greenbaum DS, Vancouver JB, Henry RC, Reinhart MA, Greenbaum RB, Dean HA, Mayle JE: Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology 98:293–301, 1990
Drossman DA, Thompson WG: The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 116:1009–1016, 1992
Clouse RE: Psychopharmacologic approaches to therapy for chest pain of presumed esophageal origin. Am J Med 92(suppl):106–113, 1992
Clouse RE: Anxiety and gastrointestinal illness. Psychiatr Clin North Am 11:399–415, 1988
Anderson KO, Dalton CB, Bradley LA, Richter JE: Stress induces alteration of esophageal pressures in healthy volunteers and non-cardiac chest pain patients. Dig Dis Sci 34:83–91, 1989
Valori RM, Kumar D, Wingate DL: Effects of different types of stress and of “prokinetic” drugs on the control of the fasting motor complex in humans. Gastroenterology 90:1890–1900, 1986
Keshavarzian A, Iber FL, Ferguson Y: Esophageal manometry and radionuclide emptying in chronic alcoholics. Gastroenterology 92:651–657, 1987
Wittmann T, Crenner F, Angel F, Hanusz L, Ringwald C, Greenier JF: Long-duration stress. Immediate and late effects on small and large bowel motility in rat. Dig Dis Sci 35:495–500, 1990
Cook IJ, Collins SM: Does acute emotional stress influence frequency or duration of gastroesophageal reflux in human subjects? Gastroenterology 90:A1380, 1986
Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, Dalton CB, Salley AN: The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 88:11–19, 1993
Gomez-Perez FJ, Rull JA, Dies H, Rodriguiez-Rivera JG, Gonzales-Barranco J, Lorzno-Castaneda O: Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: A double-blind crossover study. Pain 23:395–400, 1985
Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37:589–596, 1987
Turkington RW: Depression masquerading as diabetic neuropathy. JAMA 243:1147–1150, 1980
Couch JR, Ziegler DK, Hassanein R: Amitriptyline in the prophylaxis of migraine. Neurology 26:121–127, 1976
Gomersall JD, Stuart A: Amitriptyline in migraine prophylaxis. J Neurol Neurosurg Psychiatry 36:684–690, 1973
Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 32:671–673, 1982
MacNeill AL, Dick WC: Imipramine and rheumatoid factor. J Int Med Res 4:23–27, 1976
Fernandez F, Adams F, Holmes F: Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin. J Clin Psychopharmacol 3:167–169, 1987
Egbunike IG, Chaffee BJ: Antidepressants in the management of chronic pain syndromes. Pharmacotherapy 10:262–270, 1990
France RD: The future for antidepressants: treatment of pain. Psychopathology 20(suppl 1):99–113, 1987
Getto CJ, Sorkness CA, Howell T: Antidepressants and chronic nonmalignant pain: A review. J Pain Symptom Manage 2:9–18, 1987
Satterthwaite JR, Tollison CD, Kriegel ML: The use of tricyclic antidepressants for the treatment of intractable pain. Compr Ther 16:10–15, 1990
Heefner JD, Russell MW, Wilson ID: Irritable colon and depression. Psychosomatics 19:540–547, 1978
Steinhart MJ, Wong PY, Zarr ML: Therapeutic usefulness of amitriptyline in spastic colon syndrome. Int J Psychiatry Med 11:45–57, 1981–1982
Myren J, Groth H, Larssen SE, Larsen S: The effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 17:871–875, 1982
Lancaster-Smith MJ, Prout BJ, Pinto T, Anderson JA, Schiff AA: Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand 66:33–41, 1982
Gartrell N, Mosbacher D: A case report of the irritable bowel syndrome treated with doxepin. Am J Psychiatry 139:1351–1354, 1982
Shrivastava RK, Siegel H: The role of tricyclics and benzodiazepine compounds in the treatment of irritable gut syndrome and peptic ulcer disease. Psychopharm Bull 20:616–621, 1984
Greenbaum DS, Mayle JE, Vanegeren LE, Jerome JA, Mayor JW, Greenbaum RB, Matson RW, Stein GE, Dean HA, Halvorsen NA, Rosen LW: Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig Dis Sci 32:257–266, 1987
Klein KB: Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 95:232–241, 1988
Mayer EA, Raybould HE: Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 99:1688–1704, 1990
Ritchie J: Pain from distention of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 14:125–132, 1973
Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, Shabsin H, Schuster MM: Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 98:1187–1192, 1990
Richter JE, Barish CF, Castell DO: Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 91:845–852, 1986
Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R: Abnormal perception of visceral pain in response to gastric distention in chronic idiopathic dyspepsia: The irritable stomach syndrome. Dig Dis Sci 36:1249–1254, 1991
Clouse RE, McCord GS, Lustman PJ, Edmundowicz SA: Clinical correlates of abnormal sensitivity to intraesophageal balloon distension. Dig Dis Sci 36:1040–1045, 1991
Mearin F, Cucala M, Azpiroz F, Malagelada J-R: The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 101:999–1006, 1991
Bradette M, Pare P, Douville P, Morin A: Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 36:52–58, 1991
George AA, Tsuchiyose M, Dooley CP: Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 101:3–6, 1991
Talley NJ: Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: Clinical implications. Aliment Pharmacol Ther 6:273–289, 1992
Baldessarini RJ: Current status of antidepressants: Clinical pharmacology and therapy. J Clin Psychiatry 50:117–126, 1989
Rudorfer MV, Potter WZ: Antidepressants: A comparative review of the clinical pharmacology and therapeutic use of the “newer” versus the “older” drugs. Drugs 37:713–738, 1989
Stark M Jr, Maher K, Gupta P, Epstein S, Cannon R, Lewis J, Benjamin S: Visceral afferent blockade with ondansetron (Zofran) increases nociceptive thresholds in patients with chest pain of undetermined etiology (CPUE). Am J Gastroenterol 86:1305 (abstract), 1991
Hasler WL, Soudah HC, Owyang C: A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention. Gastroenterology 104:1390–1397, 1993
Blackwell B: A biopsychosocial perspective to psychotropic drug use in psychophysiologic conditions. Psychopharmacol Bull 20:629–634, 1984
Camilleri M, Prather CM: The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med 116:1001–1008, 1992
Clouse RE, Lustman PJ, Geisman RA, Alpers DH: Antidepressant therapy in 138 patients with irritable bowel syndrome: A five-year clinical experience. Aliment Pharmacol Ther 8:1994
Holmes KM, Salter RH: Irritable bowel syndrome—a safe diagnosis? Br Med J 285:1533–1534, 1982
Hawkins CF, Cockel R: The prognosis and risk of missing malignant disease in patients with unexplained and functional diarrhoea. Gut 12:208–211, 1971
Harvey RF, Mauad EC, Brown AM: Prognosis in the irritable bowel syndrome: A 5-year prospective study. Lancet 1:963–965, 1987
Waller SL, Misiewicz JJ: Prognosis in the irritable-bowel syndrome. A prospective study. Lancet 2:753–756, 1969
Appleton WS: Fourth psychoactive drug usage guide. J Clin Psychiatry 43:12–27, 1982
Dawson GW, Jue SG, Brogden RN: Alprazolam: A review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Drugs 27:132–147, 1984
Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250–1256, 1992
US Department of Health and Human Services, Public Health Service: Depression in Primary Care: Detection, Diagnosis, and Treatment, Vol 5. AHCPR Publication No. 93-0552, April 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clouse, R.E. Antidepressants for functional gastrointestinal syndromes. Digest Dis Sci 39, 2352–2363 (1994). https://doi.org/10.1007/BF02087651
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02087651